Join the Myobloc group to help and get support from people like you.
Myobloc News
FDA Approves Myobloc (rimabotulinumtoxinB) Injection for Chronic Sialorrhea
LOUISVILLE, Ky., Aug. 26, 2019 /PRNewswire/ – US WorldMeds, LLC announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (sBLA) for...
FDA Medwatch Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)
FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen...
FDA Medwatch Alert: Botox, Botox Cosmetic (Botulinum toxin Type A), Myobloc (Botulinum toxin Type B)
[Posted 02/07/2008] FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic. FDA has received reports of systemic adverse reactions including respiratory...
Ask a question
To post your own question to this support group, sign in or create an account.